XML 18 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Unaudited Condensed Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash Flows from Operating Activities:    
Net income $ 2,403,751 $ 1,601,840
Adjustments to reconcile net income to net cash used in operating activities:    
Interest earned on cash and securities held in Trust Account (2,636,791) (1,792,415)
Payment of general and administrative costs through IPO Promissory Note 48,000
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (39,148) (259,012)
Accrued expenses (6,098) 9,594
Net cash used in operating activities (278,286) (391,993)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (288,937,500)
Net cash used in investing activities (288,937,500)
Cash Flows from Financing Activities:    
Proceeds from sale of Public Units, net of underwriting discounts paid 281,750,000
Proceeds from sale of Private Placement Units 9,227,270
Repayment of IPO Promissory Note – related party (266,071)
Payment of offering costs (75,000) (347,154)
Net cash (used in) provided by financing activities (75,000) 290,364,045
Net Change in Cash (353,286) 1,034,552
Cash – Beginning of period 577,446
Cash – End of period 224,160 1,034,552
Non-cash investing and financing activities:    
Offering costs included in accrued offering costs 81,750
Deferred offering costs paid through IPO Promissory Note – related party 550
Deferred Underwriting Fee payable $ 10,062,500